Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine

European Journal of Clinical Pharmacology

Volumn 34, Issue 1, 1988, Pages 77-82

  Olsson, B ^a   Johansson, M ^a   Gabrielsson, J ^b   Bolme, P ^c  

^a Research and Development Department   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

bioavailability; N acetylcysteine; pharmacokinetics

Indexed keywords

ACETYLCYSTEINE;

DRUG BIOAVAILABILITY; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS;

ACETYLCYSTEINE; ADMINISTRATION, ORAL; ADULT; BIOLOGICAL AVAILABILITY; COMPARATIVE STUDY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HALF-LIFE; HUMAN; INJECTIONS, INTRAVENOUS; MALE; OXIDATION-REDUCTION; RANDOM ALLOCATION; STATISTICS; TABLETS; TIME FACTORS;

EID: 0023835113     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/BF01061422     Document Type: Article

References (22)

1. The reduction in vitro in viscosity of mucoprotein solutions by a new mucolytic agent, N-acetyl-L-cysteine
2. Effect of oral N-acetylcysteine on mucus clearance
3. A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bronchitis
4. Long-term acetylcysteine in chronic bronchitis. A double-blind controlled study
5. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: Report of a trial organized by the Swedish Society for Pulmonary Diseases
6. Treatment of paracetamol (acetaminophen) poisoning with N-acetalcysteine
7. N-acetylcysteine: Its bioavailability and interactions with ifosfamide metabolites
8. Determination of non-protein-bound N-acetylcysteine in plasma by high-performance liquid chromatography
9. Improved method for the determination of N-acetylcysteine in human plasma by high-performance liquid chromatography
10. Methodologies for the analysis of reduced and oxidised N-acetylcysteine in biological systems
11. Determination of N-acetylcysteine, intact and oxidized in plasma by column liquid chromatography and post-column derivatization
12. Metabolic studies with acetylcysteine
13. Pharmacokinetics of oral acetylcysteine: Absorption, binding and metabolism in patients with respiratory disorders
14. Toxicological, pharmacokinetic and metabolic studies on acetylcysteine
15. Pharmacokinetics of N-acetylcystine in man
16. Pharmacokinetic parameter estimates from several least squares procedures: superiority of extended least squares
17. The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time
18. Modulation of pneumotoxicity by cellular glutathione and precursors
19. N-acetylcysteine for paracetamol overdose